MORELLO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 3.807
AS - Asia 2.587
EU - Europa 2.455
SA - Sud America 491
AF - Africa 85
OC - Oceania 11
Totale 9.436
Nazione #
US - Stati Uniti d'America 3.686
SG - Singapore 1.116
IT - Italia 835
CN - Cina 632
BR - Brasile 396
PL - Polonia 314
DE - Germania 271
HK - Hong Kong 245
FI - Finlandia 218
VN - Vietnam 208
UA - Ucraina 165
FR - Francia 150
GB - Regno Unito 122
RU - Federazione Russa 99
IN - India 83
TR - Turchia 79
CA - Canada 65
IE - Irlanda 50
SE - Svezia 45
BD - Bangladesh 41
NL - Olanda 41
MX - Messico 37
CZ - Repubblica Ceca 31
JP - Giappone 29
IQ - Iraq 28
ES - Italia 27
AR - Argentina 24
ZA - Sudafrica 23
BE - Belgio 21
EC - Ecuador 18
ID - Indonesia 18
CO - Colombia 15
TH - Thailandia 14
AT - Austria 13
PK - Pakistan 13
VE - Venezuela 13
MA - Marocco 12
EG - Egitto 11
AU - Australia 10
ET - Etiopia 10
MY - Malesia 10
PT - Portogallo 10
GR - Grecia 9
PY - Paraguay 8
SA - Arabia Saudita 7
AZ - Azerbaigian 6
DZ - Algeria 6
PH - Filippine 6
UY - Uruguay 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
GH - Ghana 5
IR - Iran 5
JO - Giordania 5
KE - Kenya 5
PE - Perù 5
CL - Cile 4
JM - Giamaica 4
LK - Sri Lanka 4
LT - Lituania 4
NO - Norvegia 4
TW - Taiwan 4
CH - Svizzera 3
CR - Costa Rica 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
KG - Kirghizistan 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
TN - Tunisia 3
UG - Uganda 3
AL - Albania 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KH - Cambogia 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
RO - Romania 2
SV - El Salvador 2
AM - Armenia 1
BG - Bulgaria 1
EE - Estonia 1
HN - Honduras 1
MD - Moldavia 1
MT - Malta 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 9.436
Città #
Singapore 659
Ashburn 432
San Jose 324
Warsaw 303
Hong Kong 241
Fairfield 238
New York 177
The Dalles 163
Beijing 154
Helsinki 154
Woodbridge 149
Brescia 145
Chandler 139
Jacksonville 125
Los Angeles 117
Seattle 117
Munich 115
Houston 111
Ann Arbor 109
Dallas 94
Milan 94
Wilmington 93
Lauterbourg 81
Princeton 77
Des Moines 67
Cambridge 66
Ho Chi Minh City 60
Istanbul 54
Council Bluffs 51
Rome 51
Dublin 49
Boardman 46
Hanoi 46
São Paulo 44
Shanghai 43
Turku 43
Chicago 36
San Francisco 36
Moscow 33
Buffalo 30
Redondo Beach 29
Santa Clara 29
Orem 27
Nanjing 25
Frankfurt am Main 24
Tokyo 24
London 23
Brno 22
Nuremberg 22
Toronto 22
Naples 21
Brooklyn 20
Chennai 20
Montreal 20
Brussels 19
Stockholm 18
Turin 18
Denver 17
Mexico City 16
Tianjin 16
Boston 15
Charlotte 15
Johannesburg 15
Poplar 15
Changsha 14
Florence 14
Phoenix 14
Pune 14
Amsterdam 12
Baghdad 12
Mumbai 12
Verona 12
Jinan 11
Lappeenranta 11
Manchester 11
Paris 11
San Diego 11
Atlanta 10
Barlassina 10
Wroclaw 10
Addis Ababa 9
Guayaquil 9
Haiphong 9
Pavia 9
Shenyang 9
Bari 8
Belo Horizonte 8
Bergamo 8
Da Nang 8
Romola 8
Bangkok 7
Bologna 7
Bosio 7
Brasília 7
Gorlago 7
Guangzhou 7
Olomouc 7
Rio de Janeiro 7
Alessandria 6
Cairo 6
Totale 6.000
Nome #
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 292
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 290
Malnutrizione, valutazione nutrizionale e aspetti dietetici 209
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 203
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 198
OUR FOOD, OUR HEALTH: NOURISHING BIODIVERSITY TO HEAL OURSELVES AND THE PLANET Slow Food’s Position Paper on Food and Health 188
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 169
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 167
Advances in CMV Management: A Single Center Real-Life Experience 167
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 164
Serotonin receptor antagonists for highly emetogenic chemotherapy in adults 161
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 157
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 153
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 153
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 152
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 148
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment 148
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 144
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 140
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 138
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 137
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 137
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 130
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 128
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 127
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 125
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 125
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 125
Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm. 123
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 123
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 123
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 122
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 121
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 120
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 120
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 118
POST REMISSION MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 AND LEUKEMIA ASSOCIATED IMMUNOPHENOTYPE PREDICTS RELAPSE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS 118
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization. 117
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 115
A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation 115
Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study 114
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 114
Complete CD95/FAS deficiency due to complex homozygous germline TNFRSF6 mutations in an adult patient with mild autoimmune lymphoproliferative syndrome (ALPS) 111
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 110
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 109
Nutritional strategies to improve VRE control 108
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 107
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 107
P. aeruginosa bloodstream infections among hematological patients: an old or new question? 105
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: results from a retrospective multicentre study 105
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 103
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 103
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 102
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin's lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability 101
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 99
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 99
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 99
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 98
RIC Allogeneic Transplantation Improves the Overall and Progression-Free Survival of Hodgkin Lymphoma Patients Relapsing after Autologous Transplantation: A GITMO Retrospective Study Based on Time of HLA-Typing and Donor Availability. 98
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 96
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 96
Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis 95
Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplant 92
Management of invasive infections due to a rare arthroconidial yeast, saprochaete capitata, in two patients with acute hematological malignancies 86
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 82
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 77
Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial 75
Aspetti Clinici della cGVHD polmonare 73
Superiority of RIC allogeneic transplantation over conventional treatment for HL patients relapsing after autologous transplantation: a GITMO retrospective study based on time of HLA-typing and donor availability. 73
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 72
MALNUTRITION AND GVHD IN ALLOGENIC BONE MARROW TRANSPLANTATION: A PROSPECTIVE STUDY 69
Moving the Care Process in the in-Home Context: The Therapeutic Prescription 68
I diritti del malato 68
Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients 64
Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses Group 62
Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations. A report of three cases 56
A case of Severe Gastrointestinal Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation: Can We Improve the Evaluation of the “Gut Fitness”? 56
Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study 54
Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50 48
Psychosocial well-being in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their caregivers: A prospective study 31
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 26
CO41 | Monocyte activation by CAR-T cells: role of extracellular vesicles and secretome in immune modulation 19
CO43 | Fourier-transform infrared spectroscopy of plasma as a liquid biopsy for monitoring acute myeloid leukemia and extramedullary relapse following allo-HSCT 13
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR 11
Totale 9.564
Categoria #
all - tutte 41.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 0 0 0 0 0 99 55 35
2021/2022378 28 31 7 29 11 33 16 32 18 64 28 81
2022/2023451 54 12 18 40 44 99 3 54 53 13 30 31
2023/2024675 40 16 55 38 34 156 28 26 118 9 17 138
2024/20252.054 41 54 24 188 178 165 135 132 323 181 350 283
2025/20264.270 357 419 289 577 483 404 803 245 322 371 0 0
Totale 9.564